AbbVie (ABBV) EBT (2012 - 2026)

AbbVie (ABBV) has 15 years of EBT data on file, last reported at $1.0 billion in Q1 2026.

• EBT for Q1 2026 came in at $1.0 billion, down 37.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 billion (up 64.96% YoY), and the FY2025 annual result was $6.6 billion, up 77.53% from the prior year.
• EBT declined to $1.0 billion in Q1 2026 per ABBV's latest filing, from $2.7 billion in the prior quarter.
• Over five years, EBT peaked at $4.9 billion in Q1 2022 and troughed at -$2.3 billion in Q4 2024.
• A 5-year average of $1.8 billion and a median of $1.8 billion in 2024 frame the typical range for EBT.
• On a YoY basis, EBT climbed as much as 269.47% in 2024 and fell as far as 287.21% in 2024.
• A 5-year view of EBT shows it stood at $3.0 billion in 2022, then tumbled by 59.12% to $1.2 billion in 2023, then plunged by 287.21% to -$2.3 billion in 2024, then soared by 217.58% to $2.7 billion in 2025, then tumbled by 61.06% to $1.0 billion in 2026.
• Business Quant data shows ABBV's EBT at $1.0 billion in Q1 2026, $2.7 billion in Q4 2025, and $714.0 million in Q3 2025.